“A feasibility esplorative study of a novel modality of using patient reported outcomes for patients with rare cancers and melanoma (prosexplor)”., Work Paper Public Hlth, vol. 7, no. 1, Jun. 2019, doi: 10.4081/wpph.2019.9217.